Considering apoA‐I has anti‐inflammatory and antifibrotic effect as previous papers,12, 14 our results suggest that apoA‐I might be increased against lung inflammation in HP and the degradation of apoA‐I by mast cell chymase could be important for the pathogenesis of chronic HP. This evidence concerns the gene CMA1 and hypersensitivity pneumonitis.